Anthem Biosciences IPO
Anthem Biosciences IPO is priced at ₹540 to ₹570 per share ,
Each share has a face value of ₹2.
Anthem Biosciences IPO is offering its shares to the public for the first time through an IPO on the stock exchanges BSE and NSE.
The total amount they aim to raise is 5,95,61,404 shares (aggregating up to ₹3,395.00 Cr).
Anthem Biosciences IPO open date is 14 July, 2025 and the IPO will close on 16 July, 2025.
|
Check Live IPO GMP List 👈
|
|
Check Live IPO Subscription List 👈
|
|
Check All IPO Allotment List 👈
|
Upcoming
|
Anthem Biosciences IPO Details
| IPO Category Type: | Mainboard IPO |
| IPO Open: | 14 July, 2025 |
| IPO Close: | 16 July, 2025 |
| IPO Price Band: | ₹540 to ₹570 per share |
| Face Value: | ₹2 Per Equity Share |
| IPO Listing exchange: | BSE and NSE |
| IPO Issue Type: | Book Build Issue |
| IPO Size: | Approx 5,95,61,404 shares (aggregating up to ₹3,395.00 Cr) |
| Fresh Issue: | Approx Approx 5,95,61,404 shares (aggregating up to ₹3,395.00 Cr) |
| Offer for Sale: | Approx [.] |
Anthem Biosciences IPO GMP Today
Last Updated - 9 July, 2025 7:27 pm
Anthem Biosciences IPO's GMP is ₹89 on 9 July, 2025 7:27 pm. If you add this to the IPO price, which is ₹570, you get an estimated listing price of ₹659. This means there's a potential gain of 15.6% per share.The GMP is updated daily.Keep an eye on daily updates to see how the IPO price is trending.
Anthem Biosciences IPO's GMP is ₹89 on 9 July, 2025 7:27 pm. If you add this to the IPO price, which is ₹570, you get an estimated listing price of ₹659. This means there's a potential gain of 15.6% per share.The GMP is updated daily.Keep an eye on daily updates to see how the IPO price is trending.
| IPO Price : | 570 Rs |
| IPO GMP : | 89 Rs 👈 |
| Expected Listing Price : | 570+89 = 659 Rs |
| Expected IPO Gain %: | 15.6% 👈 |
| Rating : | ★★☆☆☆ |
| One Lot Shares: | 26 |
| One Lot Price: | 14,820 Rs |
| One Lot Expected Listing: | 17,134 Rs |
| One Lot Expected Profit: | 2,314 Rs 👈 |
Anthem Biosciences IPO Subscription Status
Last Updated - [.]
Anthem Biosciences IPO's subscription started on 14 July, 2025 and will close on 16 July, 2025. The retail quota is 35%, QIB is 50% and NII is 15%.
Anthem Biosciences IPO's subscription started on 14 July, 2025 and will close on 16 July, 2025. The retail quota is 35%, QIB is 50% and NII is 15%.
| QIB - Qualified Institutional Buyers: | [.]x |
| NII - Non-Institutional Investors: | [.]x |
| SNII - Small Non-Institutional Investors: - Bid below ₹10L | [.]x |
| BNII - Big Non-Institutional Investors: - Bid above ₹10L | [.]x |
| RII - Retail Individual Investor: | [.]x |
| Total: | [.]x 👈 |
Anthem Biosciences IPO Allotment Status
Anthem Biosciences IPO Allotment Status is to be decided on 17 July, 2025. The refund will be initiated on 18 July, 2025 and the shares will be credited to the Demat account on 18 July, 2025.
| IPO Registrar | Page Link |
|---|---|
| Kfin Technologies Limited | IPO Allotment Page |
| BSE | BSE IPO Allotment Page |
| NSE | NSE IPO Allotment Page |
| IPO Key | IPO Key Allotment Status Page |
Anthem Biosciences IPO Allotment 17 July, 2025 after evening.
Anthem Biosciences IPO Reservation
| Retail Quota: | 35% |
| QIB Quota: | 50% |
| NII Quota: | 15% |
| Employee Discount: | ₹50 For Employees |
Anthem Biosciences IPO Prospectus
| DRHP Draft Prospectus: | Continue Reading |
| RHP Draft Prospectus: | [.] |
| Anchor Investors List: | [.] |
Anthem Biosciences IPO Market Lot Details
| Lot Size | Shares | Amount | |
|---|---|---|---|
| Retail Minimum | 1 | 26 | ₹14820 |
| Retail Maximum | 13 | 338 | ₹192660 |
| S-HNI Minimum | 14 | 364 | ₹207480 |
| S-HNI Maximum | 67 | 1742 | ₹992940 |
| B-HNI Minimum | 68 | 1768 | ₹1007760 |
Anthem Biosciences IPO Dates
| IPO Activity | Date |
|---|---|
| Open Date: | 14 July, 2025 |
| Close Date: | 16 July, 2025 |
| Allotment Date: | 17 July, 2025 |
| Refund Date: | 18 July, 2025 |
| Shares Credit Date: | 18 July, 2025 |
| Listing Date: | 21 July, 2025 |
Anthem Biosciences Company Financial Report
| Period Ended | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
|---|---|---|---|
| Assets | 2,807.58 | 2,398.11 | 2,014.46 |
| Revenue | 1,930.29 | 1,483.07 | 1,133.99 |
| Profit After Tax | 451.26 | 367.31 | 385.19 |
| EBITDA | 683.78 | 519.96 | 446.05 |
| Net Worth | 2,409.86 | 1,924.66 | 1,740.67 |
| Reserves and Surplus | 2,298.05 | 1,815.39 | 1,628.88 |
| Total Borrowing | 108.95 | 232.53 | 125.06 |
| Amount in ₹ Crore | |||
Anthem Biosciences Company Address
| Company | Anthem Biosciences Ltd. |
|---|---|
| Address | No. 49, F1 & F2, Canara Bank Road Bommasandra Industrial Area, Phase 1, Bommasandra, Bengaluru, Karnataka, 560099 |
| Phone | +91 080 6672 400 |
| investors.abl@anthembio.com | |
| Website | https://www.anthembio.com/ |
Anthem Biosciences IPO Registrar
| Company | Kfin Technologies Limited |
|---|---|
| Phone | 04067162222, 04079611000 |
| anthem.ipo@kfintech.com | |
| Website | https://kosmic.kfintech.com/ipostatus/ |
Anthem Biosciences IPO Lead Manager
- Jm Financial Limited
- Citigroup Global Markets India Private Limited
- J.P. Morgan India Private Limited
- Nomura Financial Advisory And Securities (India) Pvt Ltd
Anthem Biosciences IPO - FAQs
Q.What is Anthem Biosciences IPO?
Ans.Anthem Biosciences IPO is a Mainboard IPO. The IPO is list on BSE and NSE.
Q.When Anthem Biosciences IPO will open?
Ans.Anthem Biosciences IPO is to open on 14 July, 2025 for Investors.
Q.What is Anthem Biosciences IPO GMP Today?
Ans.Anthem Biosciences IPO GMP Today is Check Here
Q.What is Anthem Biosciences IPO Size?
Ans.Anthem Biosciences IPO size is 5,95,61,404 shares (aggregating up to ₹3,395.00 Cr).
Q.What is Anthem Biosciences IPO Price Band?
Ans.Anthem Biosciences IPO Price Band is ₹540 to ₹570 per share.
Q.What is the Anthem Biosciences IPO Allotment Date?
Ans.Anthem Biosciences IPO allotment date is 17 July, 2025.
Q.How to check Anthem Biosciences IPO Allotment Status?
Ans.To check Anthem Biosciences IPO allotment status Check Here
Q.What is the Anthem Biosciences IPO Listing Date?
Ans.Anthem Biosciences IPO listing date is 21 July, 2025. The IPO is to list on BSE and NSE.